Vivani Medical, Inc.
Long

Vani - Vivani Medical

297
The stock looks good here. TA + Fundamentals.
1) Vivani Medical wants to bring a subdermal drug delivery implant to the diabetes market
2) Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division.
3) Notable Insider Transactions:
- Insider Purchase reported in Vivani Medical, a biopharmaceutical company developing miniaturized, long-term drug implants, for the treatment of patients with type 2 diabetes. Chairman, Gregg Williams, purchased $2.2M of #VivaniMedical shares VANI

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.